000 01732cam  2200385zi 4500
0019.912975
003CaOODSP
00520221107182702
006m     o  d f      
007cr mn|||||||||
008220630t20222022onc     o    f000 0 eng d
020 |a9780660443614
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aHP40-314/1-2022E-PDF
24500|aPrioritization guide for assessing the need for economic evidence.
250 |aVersion 1.0
264 1|aOttawa, ON : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c2022.
264 4|c©2022
300 |a1 online resource (9 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aCover title.
500 |a"February 2022."
500 |a"Protecting and empowering Canadians to improve their health."
500 |aAt head of title: National Advisory Committee on Immunization (NACI).
500 |aIssued also in French under title: Guide sur l'établissement des priorités relatives aux données économiques.
520 |a"User guide: Burden of disease -- Proposed benefit -- Overall assessment of need for economic evidence"--Pages 7-8.
650 0|aVaccination|xEconomic aspects|zCanada.
650 0|aVaccines|xEconomic aspects|zCanada.
7102 |aPublic Health Agency of Canada, |eissuing body.
7101 |aCanada. |bNational Advisory Committee on Immunization, |eissuing body.
77508|tGuide sur l'établissement des priorités relatives aux données économiques.|w(CaOODSP)9.912974
85640|qPDF|s241 KB|uhttps://publications.gc.ca/collections/collection_2022/aspc-phac/HP40-314-1-2022-eng.pdf